GRM4 and glioblastoma: In the present study, we demonstrated that LN229 cells, a GBM cell line, expressed mGluR4, and pharmacological activation of the receptor inhibited proliferation of the tumor cells, indicated by cell viability reduction, cell cycle arrest and downregulation of cyclin D1 expression.